<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36890227</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-4687</ISSN><JournalIssue CitedMedium="Internet"><Volume>615</Volume><Issue>7952</Issue><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Nature</Title><ISOAbbreviation>Nature</ISOAbbreviation></Journal><ArticleTitle>Macrophage fumarate hydratase restrains mtRNA-mediated interferon production.</ArticleTitle><Pagination><StartPage>490</StartPage><EndPage>498</EndPage><MedlinePgn>490-498</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41586-023-05720-6</ELocationID><Abstract><AbstractText>Metabolic rewiring underlies the effector functions of macrophages<sup>1-3</sup>, but the mechanisms involved remain incompletely defined. Here, using unbiased metabolomics and stable isotope-assisted tracing, we show that an inflammatory aspartate-argininosuccinate shunt is induced following lipopolysaccharide stimulation. The shunt, supported by increased argininosuccinate synthase (ASS1) expression, also leads to increased cytosolic fumarate levels and fumarate-mediated protein succination. Pharmacological inhibition and genetic ablation of the tricarboxylic acid cycle enzyme fumarate hydratase (FH) further increases intracellular fumarate levels. Mitochondrial respiration is also suppressed and mitochondrial membrane potential increased. RNA sequencing and proteomics analyses demonstrate that there are strong inflammatory effects resulting from FH inhibition. Notably, acute FH inhibition suppresses interleukin-10 expression, which leads to increased tumour necrosis factor secretion, an effect recapitulated by fumarate esters. Moreover, FH inhibition, but not fumarate esters, increases interferon-&#x3b2; production through mechanisms that are driven by mitochondrial RNA (mtRNA) release and activation of the RNA sensors TLR7, RIG-I and MDA5. This effect is recapitulated endogenously when FH is suppressed following prolonged lipopolysaccharide stimulation. Furthermore, cells from patients with systemic lupus erythematosus also exhibit FH suppression, which indicates a potential pathogenic role for this process in human disease. We therefore identify a protective role for FH in maintaining appropriate macrophage cytokine and interferon responses.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer Nature Limited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Hooftman</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-5412-4012</Identifier><AffiliationInfo><Affiliation>School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland. ahooftma@tcd.ie.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Peace</LastName><ForeName>Christian G</ForeName><Initials>CG</Initials><Identifier Source="ORCID">0000-0002-5390-6530</Identifier><AffiliationInfo><Affiliation>School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Ryan</LastName><ForeName>Dylan G</ForeName><Initials>DG</Initials><Identifier Source="ORCID">0000-0003-4553-9192</Identifier><AffiliationInfo><Affiliation>School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland. dr523@cam.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MRC Cancer Unit, University of Cambridge, Cambridge, UK. dr523@cam.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK. dr523@cam.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Day</LastName><ForeName>Emily A</ForeName><Initials>EA</Initials><Identifier Source="ORCID">0000-0003-3245-5715</Identifier><AffiliationInfo><Affiliation>School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Ming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>MRC Cancer Unit, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CECAD Research Centre, Faculty of Medicine, University of Cologne, Cologne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McGettrick</LastName><ForeName>Anne F</ForeName><Initials>AF</Initials><Identifier Source="ORCID">0000-0001-6887-7229</Identifier><AffiliationInfo><Affiliation>School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Maureen</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-1451-9906</Identifier><AffiliationInfo><Affiliation>School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montano</LastName><ForeName>Erica N</ForeName><Initials>EN</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huo</LastName><ForeName>Lihong</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toller-Kawahisa</LastName><ForeName>Juliana E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Sao Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zecchini</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>MRC Cancer Unit, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Tristram A J</ForeName><Initials>TAJ</Initials><Identifier Source="ORCID">0000-0003-0278-1878</Identifier><AffiliationInfo><Affiliation>School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bolado-Carrancio</LastName><ForeName>Alfonso</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-2330-7489</Identifier><AffiliationInfo><Affiliation>Edinburgh Cancer Research UK Centre, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casey</LastName><ForeName>Alva M</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0002-7242-3251</Identifier><AffiliationInfo><Affiliation>MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prag</LastName><ForeName>Hiran A</ForeName><Initials>HA</Initials><Identifier Source="ORCID">0000-0002-4753-8567</Identifier><AffiliationInfo><Affiliation>MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costa</LastName><ForeName>Ana S H</ForeName><Initials>ASH</Initials><AffiliationInfo><Affiliation>MRC Cancer Unit, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Matterworks, Somerville, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Los Santos</LastName><ForeName>Gabriela</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishimori</LastName><ForeName>Mariko</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wallace</LastName><ForeName>Daniel J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Venuturupalli</LastName><ForeName>Swamy</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nikitopoulou</LastName><ForeName>Efterpi</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>MRC Cancer Unit, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frizzell</LastName><ForeName>Norma</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-5080-4176</Identifier><AffiliationInfo><Affiliation>School of Medicine, University of South Carolina, Columbia, SC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johansson</LastName><ForeName>Cecilia</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-6607-5000</Identifier><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Von Kriegsheim</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4952-8573</Identifier><AffiliationInfo><Affiliation>Edinburgh Cancer Research UK Centre, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murphy</LastName><ForeName>Michael P</ForeName><Initials>MP</Initials><Identifier Source="ORCID">0000-0003-1115-9618</Identifier><AffiliationInfo><Affiliation>MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jefferies</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frezza</LastName><ForeName>Christian</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-3293-7397</Identifier><AffiliationInfo><Affiliation>MRC Cancer Unit, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CECAD Research Centre, Faculty of Medicine, University of Cologne, Cologne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Neill</LastName><ForeName>Luke A J</ForeName><Initials>LAJ</Initials><Identifier Source="ORCID">0000-0002-4333-2748</Identifier><AffiliationInfo><Affiliation>School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland. laoneill@tcd.ie.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>R01 AI164504</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS126851</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nature</MedlineTA><NlmUniqueID>0410462</NlmUniqueID><ISSNLinking>0028-0836</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 6.3.4.5</RegistryNumber><NameOfSubstance UI="D001124">Argininosuccinate Synthase</NameOfSubstance></Chemical><Chemical><RegistryNumber>2387-71-5</RegistryNumber><NameOfSubstance UI="D001125">Argininosuccinic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>30KYC7MIAI</RegistryNumber><NameOfSubstance UI="D001224">Aspartic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="C452820">DDX58 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.2.1.2</RegistryNumber><NameOfSubstance UI="D005649">Fumarate Hydratase</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005650">Fumarates</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="C452815">IFIH1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>77238-31-4</RegistryNumber><NameOfSubstance UI="D016899">Interferon-beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008070">Lipopolysaccharides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000077278">RNA, Mitochondrial</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C495348">TLR7 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nat Rev Rheumatol. 2023 May;19(5):257</RefSource><PMID Version="1">37024712</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Signal Transduct Target Ther. 2023 Sep 4;8(1):332</RefSource><PMID Version="1">37666844</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001124" MajorTopicYN="N">Argininosuccinate Synthase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001125" MajorTopicYN="N">Argininosuccinic Acid</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001224" MajorTopicYN="N">Aspartic Acid</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019069" MajorTopicYN="N">Cell Respiration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003600" MajorTopicYN="N">Cytosol</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005649" MajorTopicYN="Y">Fumarate Hydratase</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005650" MajorTopicYN="N">Fumarates</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016899" MajorTopicYN="Y">Interferon-beta</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008070" MajorTopicYN="N">Lipopolysaccharides</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008264" MajorTopicYN="Y">Macrophages</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053078" MajorTopicYN="N">Membrane Potential, Mitochondrial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055432" MajorTopicYN="N">Metabolomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="Y">Mitochondria</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077278" MajorTopicYN="Y">RNA, Mitochondrial</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing interests</b> The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>8</Day><Hour>23</Hour><Minute>18</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36890227</ArticleId><ArticleId IdType="mid">NIHMS1910116</ArticleId><ArticleId IdType="pmc">PMC10411300</ArticleId><ArticleId IdType="doi">10.1038/s41586-023-05720-6</ArticleId><ArticleId IdType="pii">10.1038/s41586-023-05720-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mills EL et al. Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages. Cell 167, 457&#x2013;470.e13 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5863951</ArticleId><ArticleId IdType="pubmed">27667687</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills EL et al. Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1. Nature 556, 113&#x2013;117 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6047741</ArticleId><ArticleId IdType="pubmed">29590092</ArticleId></ArticleIdList></Reference><Reference><Citation>Tannahill GM. et al.. Succinate is an inflammatory signal that induces IL-1&#x3b2; through HIF-1&#x3b1;. Nature 496, 238&#x2013;242 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4031686</ArticleId><ArticleId IdType="pubmed">23535595</ArticleId></ArticleIdList></Reference><Reference><Citation>Lampropoulou V. et al. Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation. Cell Metab. 24, 158&#x2013;166 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5108454</ArticleId><ArticleId IdType="pubmed">27374498</ArticleId></ArticleIdList></Reference><Reference><Citation>Jha AK et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity 42, 419&#x2013;430 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25786174</ArticleId></ArticleIdList></Reference><Reference><Citation>Billingham LK et al. Mitochondrial electron transport chain is necessary for NLRP3 inflammasome activation. Nat. Immunol 23, 692&#x2013;704 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9098388</ArticleId><ArticleId IdType="pubmed">35484407</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills EL, Kelly B. &amp; O&#x2019;Neill LAJ Mitochondria are the powerhouses of immunity. Nat. Immunol 18, 488&#x2013;498 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28418387</ArticleId></ArticleIdList></Reference><Reference><Citation>Adam J. et al. Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling. Cancer Cell 20, 524&#x2013;537 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3202623</ArticleId><ArticleId IdType="pubmed">22014577</ArticleId></ArticleIdList></Reference><Reference><Citation>Kornberg MD et al. Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity. Science 360, 449&#x2013;453 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5924419</ArticleId><ArticleId IdType="pubmed">29599194</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphries F. et al. Succination inactivates gasdermin D and blocks pyroptosis. Science 369, 1633&#x2013;1637 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8744141</ArticleId><ArticleId IdType="pubmed">32820063</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams NC et al. Signaling metabolite L-2-hydroxyglutarate activates the transcription factor HIF-1&#x3b1; in lipopolysaccharide-activated macrophages. J. Biol. Chem 298, 101501 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8784330</ArticleId><ArticleId IdType="pubmed">34929172</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordes T. et al. Immunoresponsive gene 1 and itaconate inhibit succinate dehydrogenase to modulate intracellular succinate levels. J. Biol. Chem 291, 14274&#x2013;14284 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4933182</ArticleId><ArticleId IdType="pubmed">27189937</ArticleId></ArticleIdList></Reference><Reference><Citation>Sass E, Blachinsky E, Karniely S. &amp; Pines O. Mitochondrial and cytosolic isoforms of yeast fumarase are derivatives of a single translation product and have identical amino termini. J. Biol. Chem 276, 46111&#x2013;46117 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11585823</ArticleId></ArticleIdList></Reference><Reference><Citation>Adam J. et al. A role for cytosolic fumarate hydratase in urea cycle metabolism and renal neoplasia. Cell Rep. 3, 1440&#x2013;1448 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3675675</ArticleId><ArticleId IdType="pubmed">23643539</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi T, Schumacker PT &amp; Kozmin SA Identification of fumarate hydratase inhibitors with nutrient-dependent cytotoxicity. J. Am. Chem. Soc 137, 564&#x2013;567 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4308746</ArticleId><ArticleId IdType="pubmed">25469852</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan DG et al. Disruption of the TCA cycle reveals an ATF4-dependent integration of redox and amino acid metabolism. eLife 10, e72593 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8735863</ArticleId><ArticleId IdType="pubmed">34939929</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi G. et al. Dimethyl fumarate mediates Nrf2-dependent mitochondrial biogenesis in mice and humans. Hum. Mol. Genet 26, 2864&#x2013;2873 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6251607</ArticleId><ArticleId IdType="pubmed">28460056</ArticleId></ArticleIdList></Reference><Reference><Citation>Sciacovelli M. et al. Fumarate is an epigenetic modifier that elicits epithelial-to- mesenchymal transition. Nature 537, 544&#x2013;547 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5136292</ArticleId><ArticleId IdType="pubmed">27580029</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YP et al. Malic enzyme 2 connects the Krebs cycle intermediate fumarate to mitochondrial biogenesis. Cell Metab. 33, 1027&#x2013;1041 e1028 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33770508</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao ST et al. 4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to exert anti-inflammatory effects. Nat. Commun 10, 5091 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6841710</ArticleId><ArticleId IdType="pubmed">31704924</ArticleId></ArticleIdList></Reference><Reference><Citation>Crooks DR et al. Mitochondrial DNA alterations underlie an irreversible shift to aerobic glycolysis in fumarate hydratase-deficient renal cancer. Sci. Signal 14, eabc4436 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8039187</ArticleId><ArticleId IdType="pubmed">33402335</ArticleId></ArticleIdList></Reference><Reference><Citation>Blatnik M, Frizzell N, Thorpe SR &amp; Baynes JW Inactivation of glyceraldehyde3-phosphate dehydrogenase by fumarate in diabetes: formation of S-(2-succinyl) cysteine, a novel chemical modification of protein and possible biomarker of mitochondrial stress. Diabetes 57, 41&#x2013;49 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2423377</ArticleId><ArticleId IdType="pubmed">17934141</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyrakis PA et al. Fumarate hydratase loss causes combined respiratory chain defects. Cell Rep. 21, 1036&#x2013;1047 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5668630</ArticleId><ArticleId IdType="pubmed">29069586</ArticleId></ArticleIdList></Reference><Reference><Citation>Ternette N. et al. Inhibition of mitochondrial aconitase by succination in fumarate hydratase deficiency. Cell Rep. 3, 689&#x2013;700 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3617368</ArticleId><ArticleId IdType="pubmed">23499446</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan LB et al. The proto-oncometabolite fumarate binds glutathione to amplify ROS-dependent signaling. Mol. Cell 51, 236&#x2013;248 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3775267</ArticleId><ArticleId IdType="pubmed">23747014</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng L. et al. Fumarate induces redox-dependent senescence by modifying glutathione metabolism. Nat. Commun 6, 6001 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4340546</ArticleId><ArticleId IdType="pubmed">25613188</ArticleId></ArticleIdList></Reference><Reference><Citation>Bambouskova M. et al. Electrophilic properties of itaconate and derivatives regulate the I&#x3ba;B&#x3b6;&#x2013;ATF3 inflammatory axis. Nature 556, 501&#x2013;504 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6037913</ArticleId><ArticleId IdType="pubmed">29670287</ArticleId></ArticleIdList></Reference><Reference><Citation>Raimundo N, Vanharanta S, Aaltonen LA, Hovatta I. &amp; Suomalainen A. Downregulation of SRF&#x2013;FOS&#x2013;JUNB pathway in fumarate hydratase deficiency and in uterine leiomyomas. Oncogene 28, 1261&#x2013;1273 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19151755</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu X. et al. IFN-&#x3b3; suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins. Immunity 24, 563&#x2013;574 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16713974</ArticleId></ArticleIdList></Reference><Reference><Citation>Angel P, Hattori K, Smeal T. &amp; Karin M. The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1. Cell 55, 875&#x2013;885 (1988).</Citation><ArticleIdList><ArticleId IdType="pubmed">3142689</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickinson SE et al. Inhibition of activator protein-1 by sulforaphane involves interaction with cysteine in the cFos DNA-binding domain: implications for chemoprevention of UVB-induced skin cancer. Cancer Res. 69, 7103&#x2013;7110 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2741483</ArticleId><ArticleId IdType="pubmed">19671797</ArticleId></ArticleIdList></Reference><Reference><Citation>de Waal Malefyt R, Abrams J, Bennett B, Figdor CG &amp; de Vries JE Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med 174, 1209&#x2013;1220 (1991).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2119001</ArticleId><ArticleId IdType="pubmed">1940799</ArticleId></ArticleIdList></Reference><Reference><Citation>Luan HH et al. GDF15 is an inflammation-induced central mediator of tissue tolerance. Cell 178, 1231&#x2013;1244.e11 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6863354</ArticleId><ArticleId IdType="pubmed">31402172</ArticleId></ArticleIdList></Reference><Reference><Citation>Day EA et al. Metformin-induced increases in GDF15 are important for suppressing appetite and promoting weight loss. Nat. Metab 1, 1202&#x2013;1208 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">32694673</ArticleId></ArticleIdList></Reference><Reference><Citation>Coll AP et al. GDF15 mediates the effects of metformin on body weight and energy balance. Nature 578, 444&#x2013;448 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7234839</ArticleId><ArticleId IdType="pubmed">31875646</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y. et al. SLC25A39 is necessary for mitochondrial glutathione import in mammalian cells. Nature 599, 136&#x2013;140 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34707288</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng JH et al. Colchicine acts selectively in the liver to induce hepatokines that inhibit myeloid cell activation. Nat. Metab 3, 513&#x2013;522 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8175070</ArticleId><ArticleId IdType="pubmed">33846641</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisenstein A. et al. Activation of the transcription factor NRF2 mediates the anti-inflammatory properties of a subset of over-the-counter and prescription NSAIDs. Immunity 55, 1082&#x2013;1095.e5 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9205175</ArticleId><ArticleId IdType="pubmed">35588739</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadullah K. et al. Influence of monomethylfumarate on monocytic cytokine formation&#x2014; explanation for adverse and therapeutic effects in psoriasis? Arch. Dermatol. Res 289, 623&#x2013;630 (1997).</Citation><ArticleIdList><ArticleId IdType="pubmed">9444385</ArticleId></ArticleIdList></Reference><Reference><Citation>Arts RJ et al. Glutaminolysis and fumarate accumulation integrate immunometabolic and epigenetic programs in trained immunity. Cell Metab. 24, 807&#x2013;819 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5742541</ArticleId><ArticleId IdType="pubmed">27866838</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan DG et al. Nrf2 activation reprograms macrophage intermediary metabolism and suppresses the type I interferon response. iScience 25, 103827 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8844662</ArticleId><ArticleId IdType="pubmed">35198887</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanmugasundaram K. et al. The oncometabolite fumarate promotes pseudohypoxia through noncanonical activation of NF-&#x3ba;B signaling. J. Biol. Chem 289, 24691&#x2013;24699 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4148891</ArticleId><ArticleId IdType="pubmed">25028521</ArticleId></ArticleIdList></Reference><Reference><Citation>West AP et al. Mitochondrial DNA stress primes the antiviral innate immune response. Nature 520, 553&#x2013;557 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4409480</ArticleId><ArticleId IdType="pubmed">25642965</ArticleId></ArticleIdList></Reference><Reference><Citation>Sliter DA et al. Parkin and PINK1 mitigate STING-induced inflammation. Nature 561, 258&#x2013;262 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7362342</ArticleId><ArticleId IdType="pubmed">30135585</ArticleId></ArticleIdList></Reference><Reference><Citation>McArthur K. et al. BAK/BAX macropores facilitate mitochondrial herniation and mtDNA efflux during apoptosis. Science 359, eaao6047 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29472455</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang EV, McDonald JG, Russell DW &amp; Cyster JG Oxysterol restraint of cholesterol synthesis prevents AIM2 inflammasome activation. Cell 171, 1057&#x2013;1071.e11 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5693620</ArticleId><ArticleId IdType="pubmed">29033131</ArticleId></ArticleIdList></Reference><Reference><Citation>Haag SM et al. Targeting STING with covalent small-molecule inhibitors. Nature 559, 269&#x2013;273 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29973723</ArticleId></ArticleIdList></Reference><Reference><Citation>Stunz LL et al. Inhibitory oligonucleotides specifically block effects of stimulatory CpG oligonucleotides in B cells. Eur. J. Immunol 32, 1212&#x2013;1222 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">11981808</ArticleId></ArticleIdList></Reference><Reference><Citation>Prantner D. et al. 5,6-Dimethylxanthenone-4-acetic acid (DMXAA) activates stimulator of interferon gene (STING)-dependent innate immune pathways and is regulated by mitochondrial membrane potential. J. Biol. Chem 287, 39776&#x2013;39788 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3501038</ArticleId><ArticleId IdType="pubmed">23027866</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhir A. et al. Mitochondrial double-stranded RNA triggers antiviral signalling in humans. Nature 560, 238&#x2013;242 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6570621</ArticleId><ArticleId IdType="pubmed">30046113</ArticleId></ArticleIdList></Reference><Reference><Citation>Tigano M, Vargas DC, Tremblay-Belzile S, Fu Y. &amp; Sfeir A. Nuclear sensing of breaks in mitochondrial DNA enhances immune surveillance. Nature 591, 477&#x2013;481 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33627873</ArticleId></ArticleIdList></Reference><Reference><Citation>Kariko K, Buckstein M, Ni H. &amp; Weissman D. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23, 165&#x2013;175 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">16111635</ArticleId></ArticleIdList></Reference><Reference><Citation>Rai P. et al. IRGM1 links mitochondrial quality control to autoimmunity. Nat. Immunol 22, 312&#x2013;321 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7906953</ArticleId><ArticleId IdType="pubmed">33510463</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruger A. et al. Human TLR8 senses UR/URR motifs in bacterial and mitochondrial RNA. EMBO Rep. 16, 1656&#x2013;1663 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4687425</ArticleId><ArticleId IdType="pubmed">26545385</ArticleId></ArticleIdList></Reference><Reference><Citation>Pichlmair A. et al.. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5&#x2032;-phosphates. Science 314, 997&#x2013;1001 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">17038589</ArticleId></ArticleIdList></Reference><Reference><Citation>Koshiba T, Yasukawa K, Yanagi Y. &amp; Kawabata S. Mitochondrial membrane potential is required for MAVS-mediated antiviral signaling. Sci. Signal 4, ra7 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21285412</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S. et al. Mitochondrial double-stranded RNAs govern the stress response in chondrocytes to promote osteoarthritis development. Cell Rep. 40, 111178 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35947956</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasa SMM et al. Inflammaging is driven by upregulation of innate immune receptors and systemic interferon signaling and is ameliorated by dietary restriction. Cell Rep. 39, 111017 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35767948</ArticleId></ArticleIdList></Reference><Reference><Citation>Buskiewicz IA et al. Reactive oxygen species induce virus-independent MAVS oligomerization in systemic lupus erythematosus. Sci. Signal 9, ra115 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5321043</ArticleId><ArticleId IdType="pubmed">27899525</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Limon P. et al. Atherosclerosis and cardiovascular disease in systemic lupus erythematosus: effects of in vivo statin treatment. Ann. Rheum. Dis 74, 1450&#x2013;1458 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">24658835</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis P, Cunnington P. &amp; Hughes GR Double-stranded RNA antibodies in systemic lupus erythematosus. Ann. Rheum. Dis 34, 239&#x2013;243 (1975).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1006404</ArticleId><ArticleId IdType="pubmed">1155982</ArticleId></ArticleIdList></Reference><Reference><Citation>Caielli S. et al. Oxidized mitochondrial nucleoids released by neutrophils drive type I interferon production in human lupus. J. Exp. Med 213, 697&#x2013;713 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4854735</ArticleId><ArticleId IdType="pubmed">27091841</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar P. et al. Reduced expression of mitochondrial fumarate hydratase in progressive multiple sclerosis contributes to impaired in vitro mesenchymal stromal cell-mediated neuroprotection. Mult. Scler 28, 1179&#x2013;1188 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9189727</ArticleId><ArticleId IdType="pubmed">34841955</ArticleId></ArticleIdList></Reference><Reference><Citation>Zecchini V. et al. Fumarate induces vesicular release of mtDNA to drive innate immunity. Nature 10.1038/s41586-023-05770-w (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-05770-w</ArticleId><ArticleId IdType="pmc">PMC10017517</ArticleId><ArticleId IdType="pubmed">36890229</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q. et al. RNA editing underlies genetic risk of common inflammatory diseases. Nature 608, 569&#x2013;577 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9790998</ArticleId><ArticleId IdType="pubmed">35922514</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang Z. et al. MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights. Nucleic Acids Res. 49, W388&#x2013;W396 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8265181</ArticleId><ArticleId IdType="pubmed">34019663</ArticleId></ArticleIdList></Reference><Reference><Citation>Anders S. &amp; Huber W. Differential expression analysis for sequence count data. Genome Biol. 11, R106 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3218662</ArticleId><ArticleId IdType="pubmed">20979621</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah AD, Goode RJA, Huang C, Powell DR &amp; Schittenhelm RB LFQ-Analyst: an easy-to-use interactive web platform to analyze and visualize label-free proteomics data preprocessed with MaxQuant. J. Proteome Res 19, 204&#x2013;211 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31657565</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuleshov MV et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44, W90&#x2013;W97 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4987924</ArticleId><ArticleId IdType="pubmed">27141961</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545&#x2013;15550 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1239896</ArticleId><ArticleId IdType="pubmed">16199517</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>